Spruce Biosciences, Inc. (SPRB) Tops Q1 EPS by 8c

Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q1 EPS of ($0.28), $0.08 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $2 million versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Qualcomm targets $40B in non-handset revenue by fiscal 2029
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal